AIM
AIM ImmunoTech
30 hedge funds and large institutions have $3.01M invested in AIM ImmunoTech in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$29.9K | |
| 2 | +$25K | |
| 3 | +$14.8K | |
| 4 |
DBRC
D.B. Root & Company
Pittsburgh,
Pennsylvania
|
+$8.07K |
| 5 |
Renaissance Technologies
New York
|
+$6.78K |
Top Sellers
| 1 | -$117K | |
| 2 | -$73.4K | |
| 3 | -$17K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.9K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9K |